Literature DB >> 32495926

Does amantadine have a protective effect against COVID-19?

Albert Cortés Borra1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32495926     DOI： 10.5603/PJNNS.a2020.0041

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN： 0028-3843            Impact factor:   1.621


× No keyword cloud information.
  8 in total

1.  Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.

Authors:  Conor Fearon; Alfonso Fasano
Journal:  Int Rev Neurobiol       Date:  2022-04-20       Impact factor: 4.280

2.  Observational study of people infected with SARS-Cov-2, treated with amantadine.

Authors:  Gonzalo Emiliano Aranda-Abreu; José D Aranda-Martínez; Ramiro Araújo; María Elena Hernández-Aguilar; Deissy Herrera-Covarrubias; Fausto Rojas-Durán
Journal:  Pharmacol Rep       Date:  2020-10-10       Impact factor: 3.024

3.  Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2.

Authors:  Albert Cortés-Borra; Gonzalo Emiliano Aranda-Abreu
Journal:  Pharmacol Rep       Date:  2021-02-18       Impact factor: 3.024

4.  Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.

Authors:  Miao-Miao Zhao; Wei-Li Yang; Fang-Yuan Yang; Li Zhang; Wei-Jin Huang; Wei Hou; Chang-Fa Fan; Rong-Hua Jin; Ying-Mei Feng; You-Chun Wang; Jin-Kui Yang
Journal:  Signal Transduct Target Ther       Date:  2021-03-27

Review 5.  Parkinson's Disease in Light of the COVID-19 Pandemic.

Authors:  Anna Drelich-Zbroja; Mateusz Cheda; Maryla Kuczyńska; Izabela Dąbrowska; Ewa Kopyto; Izabela Halczuk
Journal:  Brain Sci       Date:  2022-01-21

6.  Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone.

Authors:  Monika Kadela-Tomanek; Maria Jastrzębska; Krzysztof Marciniec; Elwira Chrobak; Ewa Bębenek; Stanisław Boryczka
Journal:  Pharmaceutics       Date:  2021-05-23       Impact factor: 6.321

Review 7.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

8.  Use of amantadine in a patient with SARS-CoV-2.

Authors:  Gonzalo Emiliano Aranda-Abreu; José Dolores Aranda-Martínez; Ramiro Araújo
Journal:  J Med Virol       Date:  2020-06-24       Impact factor: 20.693
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.